MlrB的酶机制是通过Sphingopyxis sp. 催化线性化微囊的. 美国商业银行-05
Junhui Teng1, Qianqian Xu1, Haiyang Zhang1
1School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China.
Frontiers in microbiology
|May 7, 2024
概括
这项研究揭示了线性微囊酶 (MlrB) 在降解有毒微囊中的酶机制. 计算机模拟和实验阐明了MLRB如何分解这些有害的蓝菌毒素.
科学领域:
- 生物化学 生物化学
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
背景情况:
- 微囊 (MCs) 是优食水中普遍存在的蓝藻细菌毒素.
- 线性微囊是有毒的中间代谢产物.
- 线性微囊酶 (MlrB) 来自 * Sphingopyxis * sp. USTB-05催化了MC降解的过程.
研究的目的:
- 阐明MlrB在生物降解线性化微囊中的酶机制.
- 为了确定MlrB的关键活性点和催化残留物.
- 了解氨基酸残留在基质稳定中的协同作用.
主要方法:
- 通过与青素识别酶的比较,对MLRB结构的同质模型.
- 分子对接以预测关键活性位点.
- 位点定向突变发生,用于实验性验证活性位点.
主要成果:
- 通过MlrB提出了对线性MC生物降解的综合酶机制.
- 从S77到H307的质子转移启动了对MC键的核友性攻击.
- 确定了四种残留物 (K80,Y171,N173,D245) 来稳定基质和过渡状态.
结论:
- 这项研究为线性化微囊的MLRB介导生物降解提供了第一个详细的酶机制.
- 结合了计算模拟和实验验证的机械洞察力.
- 为制定减轻微囊污染的策略提供了基础.
相关概念视频
Microbial Bioremediation of Pesticides
85
Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
85
Microbial Corrosion
93
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
93
Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219


